Nuclear medicine in the assessment of differentiated thyroid cancer
- 1 April 2008
- journal article
- review article
- Published by Elsevier BV in Clinical Radiology
- Vol. 63 (4), 453-463
- https://doi.org/10.1016/j.crad.2007.08.002
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patientsClinical Endocrinology, 2006
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2001
- Preparation by Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal Are Comparable for the Detection of Residual Differentiated Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2001
- A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or CancerJournal of Clinical Endocrinology & Metabolism, 1999
- Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patientsSurgery, 1999
- Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1998
- Thyroid Remnant 131I Ablation for Papillary and Follicular Thyroid CarcinomaThyroid®, 1997
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerAmerican Journal Of Medicine, 1994
- Influence of Diagnostic Radioiodines on the Uptake of Ablative Dose of Iodine-131Thyroid®, 1994